Hepatitis B is the most common serious liver infection and is the cause of up to 80 percent of all liver cancers worldwide. Unfortunately, even though overall liver cancer rates are decreasing thanks to available vaccines, disparities in education and health access continue to put Asian Americans, Native Hawaiians and Pacific Islanders (AA&NHPI) at a clear and critical disadvantage—over half of the estimated 2 million people infected in the United States are AA&NHPIs and this group is 2.4 times more likely to be diagnosed with liver disease than non-Hispanic Whites.
1 in 12 Asian Americans has hepatitis B. Could you be one of them? Get tested. Get vaccinated. Get treated.
- Hepatitis B Prevention and Care at Community Health Centers
- Consumer and Patient Principles for Electronic Health Information Exchange
- Joint Comments on Group Health Plans
- Comments on Clinical Quality Measures
- Joint Comments on Health Risk Assessment Guidance
- Viral Hepatitis Hill Visit Talking Points
- World Hepatitis Day Presidential Proclamation
- Hepatitis B: What Asian and Pacific Islander Americans Need to Know fact sheet, also available in Chinese, Korean, Tagalog, and Vietnamese.
- The Institute of Medicine’s 2010 Hepatitis and Liver Cancer Report Brief
- H.R.3974 – The first viral hepatitis and liver cancer prevention legislation.
- Hepatitis B Foundation (www.hepb.org)
- Archived Resources
- “Silent Killer” Video (WithinReach 2011)
- The Hepatitis B Epidemic in AA and NHPI Communities (webinar; download here)
- A Call to Action: JP Jael (podcast)
- A Call to Action: Jane Pan (podcast)
- A Call to Action: Corinna Dan (podcast)
- Hepatitis B Advocacy: Interview with Dr. Sam So (podcast)
- Hepatitis B Advocacy: Interview with Fiona Ma (podcast)
- Hepatitis B Advocacy: Interview with Ted Fang (podcast)